124 related articles for article (PubMed ID: 38513529)
1. Analysis of drug-impregnated paper samples seized in English prisons between 2018 and 2020.
Akca AA; Couchman L; Frinculescu A; Johnston A
Forensic Sci Int; 2024 Apr; 357():111991. PubMed ID: 38513529
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cannabinoid receptor agonists profile in infused papers seized in Brazilian prisons.
Rodrigues TB; Souza MP; de Melo Barbosa L; de Carvalho Ponce J; Júnior LFN; Yonamine M; Costa JL
Forensic Toxicol; 2022 Jan; 40(1):119-124. PubMed ID: 36454481
[TBL] [Abstract][Full Text] [Related]
3. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
[TBL] [Abstract][Full Text] [Related]
4. Large-scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons.
Norman C; McKirdy B; Walker G; Dugard P; NicDaéid N; McKenzie C
Drug Test Anal; 2021 Mar; 13(3):644-663. PubMed ID: 33058556
[TBL] [Abstract][Full Text] [Related]
5. A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations.
Norman C; Halter S; Haschimi B; Acreman D; Smith J; Krotulski AJ; Mohr ALA; Logan BK; NicDaéid N; Auwärter V; McKenzie C
Drug Test Anal; 2021 Apr; 13(4):841-852. PubMed ID: 33463894
[TBL] [Abstract][Full Text] [Related]
6. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
Ralphs R; Williams L; Askew R; Norton A
Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
[TBL] [Abstract][Full Text] [Related]
7. Detection of anabolic-androgenic steroids in e-cigarettes seized from prisons: A case study.
Harries RL; Norman C; Reid R; Nic Daéid N; Nisbet LA
Forensic Sci Int; 2024 Mar; 356():111965. PubMed ID: 38359752
[TBL] [Abstract][Full Text] [Related]
8. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons.
Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C
Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649
[TBL] [Abstract][Full Text] [Related]
9. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
[TBL] [Abstract][Full Text] [Related]
10. Detection of AP-237 and synthetic cannabinoids on an infused letter sent to a German prisoner.
Giorgetti A; Brunetti P; Pelotti S; Auwärter V
Drug Test Anal; 2022 Oct; 14(10):1779-1784. PubMed ID: 35918775
[TBL] [Abstract][Full Text] [Related]
11. Producing the 'problem' of new psychoactive substances (NPS) in English prisons.
Duke K
Int J Drug Policy; 2020 Jun; 80():102479. PubMed ID: 31155432
[TBL] [Abstract][Full Text] [Related]
12. Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison.
Strang J; Gossop M; Heuston J; Green J; Whiteley C; Maden A
Addiction; 2006 Aug; 101(8):1125-32. PubMed ID: 16869842
[TBL] [Abstract][Full Text] [Related]
13. Changing trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence, and modes of use.
Marland V; Reid R; Brandon AM; Hill K; Cruickshanks F; McKenzie C; Norman C; Nic Daéid N; Menard H
Drug Test Anal; 2024 May; 16(5):457-472. PubMed ID: 37587559
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and predictors of psychoactive substance use among men in prisons].
Caravaca-Sánchez F; Falcón Romero M; Luna A
Gac Sanit; 2015; 29(5):358-63. PubMed ID: 26228003
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for substitution treatments in prison populations].
Michel L; Maguet O
Encephale; 2005; 31(1 Pt 1):92-7. PubMed ID: 15971645
[TBL] [Abstract][Full Text] [Related]
16. A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants.
Soni A; Walters P
Int J Prison Health; 2019 Aug; 16(1):67-77. PubMed ID: 32040271
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with psychoactive substance use among a sample of prison inmates in Ilesa, Nigeria.
Amdzaranda PA; Fatoye FO; Oyebanji AO; Ogunro AS; Fatoye GK
Niger Postgrad Med J; 2009 Jun; 16(2):109-14. PubMed ID: 19606190
[TBL] [Abstract][Full Text] [Related]
18. New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances.
Chiappini S; Vaccaro G; Mosca A; Miuli A; Stigliano G; Stefanelli G; Giovannetti G; Carullo R; d'Andrea G; Di Carlo F; Cavallotto C; Pettorruso M; Di Petta G; Corkery JM; Guirguis A; Stair JL; Martinotti G; Fazel S; Schifano F
Neurosci Biobehav Rev; 2024 Jul; 162():105691. PubMed ID: 38733894
[TBL] [Abstract][Full Text] [Related]
19. Drug abuse of Finnish male prisoners in 1995.
Korte T; Pykäläinen J; Seppälä T
Forensic Sci Int; 1998 Nov; 97(2-3):171-83. PubMed ID: 9871996
[TBL] [Abstract][Full Text] [Related]
20. New Psychoactive Substances and Violence within a UK Prison Setting.
Mason R; Smith M; Onwuegbusi T; Roberts A
Subst Use Misuse; 2022; 57(14):2146-2150. PubMed ID: 36269768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
